Xalatan
- Product NDC
- 0013-8303
- 11-digit product format
- 000138303
- Labeler code
- 0013
- Product ID
- 0013-8303_bd6c67b9-3ea0-4ffb-acff-a3692f09f71f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- latanoprost
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Labeler
- PFIZER LABORATORIES DIV PFIZER INC
- Application
- NDA020597
- Marketing category
- NDA
- Marketing start
- 1995-03-20
- Marketing end
- 0000-00-00
- Substance
- LATANOPROST
- Active strength
- 50 ug/mL
- Pharmacologic classes
- Prostaglandin Analog [EPC], Prostaglandins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LATANOPROST | ACTIVE INGREDIENT | 6Z5B6HVF6O | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| LATANOPROST | ACTIVE MOIETY | 6Z5B6HVF6O | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | 22ADO53M6F | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | XALATAN (LATANOPROST) SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 12 | |
| latanoprost | ACTIVE INGREDIENT | 6Z5B6HVF6O | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
| latanoprost | ACTIVE MOIETY | 6Z5B6HVF6O | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
| Benzalkonium chloride | INACTIVE INGREDIENT | F5UM2KM3W7 | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
| sodium phosphate, dibasic anhydrous | INACTIVE INGREDIENT | 22ADO53M6F | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | XALATAN (LATANOPROST) SOLUTION [DISPENSING SOLUTIONS, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0013-8303 | XALATAN (LATANOPROST) SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | 25 | Legacy NDC | 20241025_f4e73059-5ba0-4d73-9ea1-09d8d654e844.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0013-8303-04 | 00013830304 | 1 BOTTLE, DROPPER in 1 CARTON (0013-8303-04) > 2.5 mL in 1 BOTTLE, DROPPER | 1995-03-20 | 0000-00-00 | No | No | Current |